Cross Country Healthcare, Inc.
CCRNNASDAQHealthcare● Active
$13.18
+$0.00(+0.03%)
Market Cap$426144986
P/E Ratio—
52W High$14.99
52W Low$7.43
Cross Country Healthcare, Inc. (CCRN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CCRN · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
-$0.03
Est. -$0.05 · +40.0%
Revenue
$0.24B
Est. $0.24B · +1.7%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
CCRN reports quarterly as a NASDAQ-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.00B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.00B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | $0.03 | — | — | — | $0.24B | — |
| ▲ Q2 FY2026 | May 7, 2026 | -$0.05 | -$0.03 | +40.0% | $0.24B | $0.24B | +1.7% |
| ▼ Q1 FY2026 | Mar 4, 2026 | $0.03 | -$0.06 | -300.0% | $0.24B | $0.25B | -6.9% |
| ▼ Q4 FY2025 | Nov 12, 2025 | $0.04 | $0.03 | -25.0% | $0.25B | $0.25B | -1.7% |
| ▼ Q3 FY2025 | Aug 6, 2025 | $0.07 | -$0.01 | -114.3% | $0.27B | $0.29B | -6.7% |
| ▲ Q2 FY2025 | May 7, 2025 | $0.04 | $0.06 | +50.0% | $0.29B | $0.31B | -6.8% |
| ▼ Q1 FY2025 | Mar 5, 2025 | $0.11 | $0.04 | -63.6% | $0.31B | $0.30B | +1.6% |
| ▲ Q4 FY2024 | Nov 6, 2024 | $0.10 | $0.12 | +20.0% | $0.32B | $0.31B | +2.4% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
$0.03
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Beat
EPS Actual
-$0.03
EPS Est.
-$0.05
EPS Surpr.
+40.0%
Revenue
$0.24B
Q1 FY2026
Mar 4, 2026Miss
EPS Actual
-$0.06
EPS Est.
$0.03
EPS Surpr.
-300.0%
Revenue
$0.24B
Q4 FY2025
Nov 12, 2025Miss
EPS Actual
$0.03
EPS Est.
$0.04
EPS Surpr.
-25.0%
Revenue
$0.25B
Q3 FY2025
Aug 6, 2025Miss
EPS Actual
-$0.01
EPS Est.
$0.07
EPS Surpr.
-114.3%
Revenue
$0.27B
Q2 FY2025
May 7, 2025Beat
EPS Actual
$0.06
EPS Est.
$0.04
EPS Surpr.
+50.0%
Revenue
$0.29B
Q1 FY2025
Mar 5, 2025Miss
EPS Actual
$0.04
EPS Est.
$0.11
EPS Surpr.
-63.6%
Revenue
$0.31B
Q4 FY2024
Nov 6, 2024Beat
EPS Actual
$0.12
EPS Est.
$0.10
EPS Surpr.
+20.0%
Revenue
$0.32B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.15 | $0.15 | $0.16 | 2 |
| Q3 FY2028 | $0.10 | $0.10 | $0.10 | 2 |
| Q2 FY2028 | $0.01 | $0.02 | $0.02 | 2 |
| Q1 FY2028 | $-0.03 | $-0.03 | $-0.03 | 2 |
| Q4 FY2027 | $0.09 | $0.10 | $0.10 | 1 |
| Q3 FY2027 | $0.07 | $0.07 | $0.08 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.3B | $0.3B | $0.3B | 2 |
| Q3 FY2028 | $0.3B | $0.3B | $0.3B | 2 |
| Q2 FY2028 | $0.3B | $0.3B | $0.3B | 2 |
| Q1 FY2028 | $0.3B | $0.3B | $0.3B | 2 |
| Q4 FY2027 | $0.3B | $0.3B | $0.3B | 3 |
| Q3 FY2027 | $0.3B | $0.3B | $0.3B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +40.0% | $10.11 | $13.09 | +29.48% |
| ▼ Q1 FY2026 | Mar 4, 2026 | -300.0% | $8.98 | $9.13 | +1.67% |
| ▼ Q4 FY2025 | Nov 12, 2025 | -25.0% | $12.43 | $12.65 | +1.77% |
| ▼ Q3 FY2025 | Aug 6, 2025 | -114.3% | $12.84 | $13.10 | +2.02% |
| ▲ Q2 FY2025 | May 7, 2025 | +50.0% | $13.78 | $13.84 | +0.44% |
| ▼ Q1 FY2025 | Mar 5, 2025 | -63.6% | $16.97 | $16.86 | -0.65% |
| ▲ Q4 FY2024 | Nov 6, 2024 | +20.0% | $11.45 | $12.15 | +6.11% |
| ▼ Q3 FY2024 | Jul 31, 2024 | -28.6% | $18.04 | $18.24 | +1.11% |
Q2 FY2026+29.48%
Report Date
May 7, 2026
EPS Beat/Miss
+40.0%
Price Before
$10.11
Price After
$13.09
Q1 FY2026+1.67%
Report Date
Mar 4, 2026
EPS Beat/Miss
-300.0%
Price Before
$8.98
Price After
$9.13
Q4 FY2025+1.77%
Report Date
Nov 12, 2025
EPS Beat/Miss
-25.0%
Price Before
$12.43
Price After
$12.65
Q3 FY2025+2.02%
Report Date
Aug 6, 2025
EPS Beat/Miss
-114.3%
Price Before
$12.84
Price After
$13.10
Q2 FY2025+0.44%
Report Date
May 7, 2025
EPS Beat/Miss
+50.0%
Price Before
$13.78
Price After
$13.84
Q1 FY2025-0.65%
Report Date
Mar 5, 2025
EPS Beat/Miss
-63.6%
Price Before
$16.97
Price After
$16.86
Q4 FY2024+6.11%
Report Date
Nov 6, 2024
EPS Beat/Miss
+20.0%
Price Before
$11.45
Price After
$12.15
Q3 FY2024+1.11%
Report Date
Jul 31, 2024
EPS Beat/Miss
-28.6%
Price Before
$18.04
Price After
$18.24
Avg Beat Reaction+12.01%
Avg Miss Reaction+1.18%
Beat Rate3 / 8 quarters
Largest Move+29.48% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CCRN ends December
Cross Country Healthcare, Inc. (CCRN) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $-0.03 — beating the analyst consensus of $-0.05 by +40.0%. The next CCRN earnings date is expected around September 1, 2026.
Each quarter, investors track CCRN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CCRN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CCRN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CCRN earnings · 5 questionsCross Country Healthcare, Inc.'s next earnings report is expected around September 1, 2026. CCRN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CCRN historically reports after market close (AMC).
CCRN earnings datewhen is CCRN earningsCCRN next earnings datewhen does CCRN report earningsCCRN earnings calendar
▸ Source: FMP · Cross Country Healthcare, Inc. SEC filings · US GAAP · Cross Country Healthcare, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026